glp-1 weight management program eligibility criteria As more Americans turn to drugs for loss, Medicare is launching a limited to expand access for eligible beneficiaries. More details below Are you eligible? Medicare's new

Data availability The authors declare that the data generated in this study are provided within the article and its Supplementary Information files

The hype led to backlash, and a new form of stigma emerged: Ozempic shaming, where people feel judged for taking a legitimate treatment

GLP-1s, like Ozempic and Mounjaro, turn off food noise and increase signals for satiety, making people eat less and feel fuller for longer

Randomized trials and registry studies across multiple countries converge on the same finding including a Swedish study that found GLP-1 drugs associated with fewer alcohol-related hospitalizations than medications specifically approved for alcohol use disorder